These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3660321)

  • 1. [Comparison of passage, in the vitreous body, of cefotaxime and cefoperazone].
    Carlhant D; Bonissent JF; Guedes Y; Le Garrec J; Rakotoseheno JC; Colin J; Riche C
    Therapie; 1987; 42(3):267-71. PubMed ID: 3660321
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein binding of ceftriaxone, cefoperazone, and ceftizoxime.
    Hamilton RA; Kowalsky SF; McCormick EM; Echols RM
    Clin Pharm; 1987 Jul; 6(7):567-9. PubMed ID: 3480089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cefmenoxime penetration into the vitreous body of the human eye after subconjunctival injection].
    Duncker G; Eckardt C; Ullmann U
    Fortschr Ophthalmol; 1988; 85(2):210-2. PubMed ID: 3164698
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
    Frongillo RF; Galuppo L; Moretti A
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of cefoperazone and cefotaxime.
    Lode H; Kemmerich B; Koeppe P; Belmega D; Jendroschek H
    Clin Ther; 1980; 3(Spec Issue):80-8. PubMed ID: 6248221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
    Charles D; Larsen B
    Antimicrob Agents Chemother; 1986 May; 29(5):873-6. PubMed ID: 3729345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravitreous penetration of cefotaxime in man].
    Bonissent JF; Colin J; Riche C
    J Fr Ophtalmol; 1984; 7(12):823-4. PubMed ID: 6100114
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report.
    Reddy J
    N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion.
    Bertels RA; Semmekrot BA; Gerrits GP; Mouton JW
    Infection; 2008 Oct; 36(5):415-20. PubMed ID: 18791659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An analysis of bacterial culture results in infectious endophthalmitis].
    Lu J; Lin Z; Zou Y
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):355-7. PubMed ID: 11853628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialyzability of cefotaxime and mecillinam.
    el-Guinedy M; el Said W; Sabbour MS
    Chemioterapia; 1986 Jun; 5(3):208-12. PubMed ID: 3719855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intravitreal penetration of cefotaxime in man following systemic and subconjunctival administrations.
    Rubinstein E; Triester G; Avni I; Schwartzkopf R
    Ophthalmology; 1987 Jan; 94(1):30-4. PubMed ID: 3561954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of cefixime biliary clearance in cholecystectomized patients].
    Westphal JF; Jehl F; Brogard JM
    Therapie; 1994; 49(1):35-9. PubMed ID: 8091363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of cefoperazone into human skin fluid.
    Sugiyama H; Hatano T; Takayanagi K; Aoyama H; Goto T
    Clin Ther; 1985; 7(5):607-10. PubMed ID: 4053148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of formulary restriction of cefotaxime usage.
    DeVito JM; John JF
    Arch Intern Med; 1985 Jun; 145(6):1053-6. PubMed ID: 4004430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusibility of the newer cephalosporins into human interstitial fluids.
    Tan JS; Salstrom SJ; File TM
    Am J Med; 1984 Oct; 77(4C):33-6. PubMed ID: 6093516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on cefoperazone in renal transplantation].
    Shiraiwa K; Sasagawa M; Tsurui A; Tanaka T; Ikeda R; Taniguchi T; Ben A; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1985 Apr; 31(4):723-9. PubMed ID: 3898775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.